Mapping the active site of factor Xa by selective inhibitors: An NMR and MD study

scientific article published on February 15, 1998

Mapping the active site of factor Xa by selective inhibitors: An NMR and MD study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/(SICI)1097-0134(19980215)30:3<264::AID-PROT6>3.0.CO;2-K
P953full work available at URLhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0134(19980215)30:3%3C264::AID-PROT6%3E3.0.CO;2-K
https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0134(19980215)30:3%3C264::AID-PROT6%3E3.0.CO;2-K
P698PubMed publication ID9517542

P50authorFranca FraternaliQ37374230
Vladimír SklenářQ41651960
R A AtkinsonQ67802265
P2093author name stringV. Saudek
P. Safar
P. Strop
P. Palmas
P. Wildgoose
B. T. Doan
Q. T. Do
P2860cites workJournal of Magnetic ResonanceQ3186925
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia BQ24562944
Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombinQ27729322
Structure of human des(1-45) factor Xa at 2.2 A resolutionQ27731982
The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factorQ27732597
X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognitionQ27734011
WHAT IF: a molecular modeling and drug design programQ27860734
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutionsQ27860828
Conservation and variability in the structures of serine proteinases of the chymotrypsin familyQ28280120
Turns in peptides and proteinsQ28282176
The coagulation cascade: initiation, maintenance, and regulationQ28610148
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanesQ29397708
Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSAQ29616475
Proposed cation-pi mediated binding by factor Xa: a novel enzymatic mechanism for molecular recognition.Q40467984
Biochemistry of factor X.Q40763245
Role of residue 99 at the S2 subsite of factor Xa and activated protein C in enzyme specificityQ41166210
A new type of synthetic peptide library for identifying ligand-binding activityQ45106336
An all atom force field for simulations of proteins and nucleic acidsQ46625508
Molecular dynamics with coupling to an external bathQ57569060
Molecular silverware. I. General solutions to excluded volume constrained problemsQ58473565
Validation of the general purpose Tripos 5.2 force fieldQ61463648
Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor XaQ68770626
Identification of protein-mediated indirect NOE effects in a disaccharide-Fab' complex by transferred ROESYQ72531121
A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombinQ72673525
Computer-optimized homonuclear TOCSY experiments with suppression of cross relaxationQ128036879
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)264-274
P577publication date1998-02-01
1998-02-15
P1433published inProteinsQ7251514
P1476titleMapping the active site of factor Xa by selective inhibitors: an NMR and MD study
Mapping the active site of factor Xa by selective inhibitors: An NMR and MD study
P478volume30

Reverse relations

cites work (P2860)
Q30327033Accuracy of bound peptide structures determined by exchange transferred nuclear Overhauser data: a simulation study.
Q58572895Applications of NMR in drug discovery
Q58616267Factor Xa: simulation studies with an eye to inhibitor design
Q43941686Mapping of the catalytic groove preferences of factor Xa reveals an inadequate selectivity for its macromolecule substrates.
Q60214185Production of stable isotope enriched antimicrobial peptides in Escherichia coli: an application to the production of a 15N-enriched fragment of lactoferrin
Q33540693Synthetic inhibitors of thrombin and factor Xa: from bench to bedside
Q40150944Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor

Search more.